Building expansion continues at Lohmann Animal Health International
Work on the center is scheduled to be completed in December. It is the final phase of the $8.8 million expansion that began in 2008.
“Our new Research & Development Center provides needed laboratory space,” Lohmann Animal Health International CEO Dave Zacek said. “The overall multi-million dollar expansion has given us greater research and production capacity to meet the increased industry demands for Lohmann vaccines.”